Location: United States, California, San Francisco
Mentions in press and media 2
| Date | Title | Description |
| 22.07.2017 | CMC Biologics Enters into Development and Manufacturing Agreement with Trellis BioScience | Development of Trellis’ monoclonal antibody (mAb) using CMC Biologics’ proprietary CHEF1® Expression Platform and Multi-column Continuous Chromatography (MCC) Technology CMC ICOS Biologics, Inc., a global leader in clinical and commercial ... |
| 14.02.2007 | Trellis Bioscience, cell monitoring company, raises $10M | Trellis Bioscience, a South San Francisco company that monitors cells at the individual level to assess what sort of treatments to give people, said it has raised $10 million in a second round of financing. Novartis Bioventures led the roun... |